Patents by Inventor Christiane Reeh

Christiane Reeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF AMIDOXIME CARBOXYLIC ACID ESTERS AND N-HYDROXYGUANIDINE CARBOXYLIC ACID ESTERS FOR PRODUCING PRODRUGS
    Publication number: 20110028756
    Abstract: The invention relates to a method for improving the bioavailability of pharmaceutical substances and for allowing the pharmaceutical substances to permeate the blood-brain barrier, the pharmaceutical substances having at least one or more amidine, guanidine, N-hydroxyamidine (amidoxime) or N-hydroxyguanidine functions. The invention also relates to medicaments containing the correspondingly modified pharmaceutical substances.
    Type: Application
    Filed: July 30, 2010
    Publication date: February 3, 2011
    Applicant: Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG
    Inventors: Bernd CLEMENT, Christiane REEH, Helen HUNGELING
  • AMINO ACID DERIVATIVES USED AS PHARMACEUTICAL SUBSTANCES
    Publication number: 20110021835
    Abstract: The invention relates to a method for improving bioavailability of pharmaceutical substances and for allowing the pharmaceutical substances to permeate the blood-brain barrier, the pharmaceutical substances having at least one or more amidine, guanidine, N-hydroxyamidine (amidoxime) or N-hydroxyguanidine functions. The invention also relates to medicaments containing the correspondingly modified pharmaceutical substances.
    Type: Application
    Filed: July 30, 2010
    Publication date: January 27, 2011
    Applicant: Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG
    Inventors: Bernd CLEMENT, Christiane REEH, Helen HUNGELING
  • BIOAVAILABILITY OF ACTIVE SUBSTANCES HAVING AN AMIDINE FUNCTION IN MEDICAMENTS
    Publication number: 20090270440
    Abstract: The invention relates to the use of N,N?-dihydroxyamidine (I), N,N?-dihydroxyamidine ether (II), N,N?-dihydroxyamidine diether (III), N,N?-dihydroxyamidine ester (IV), N,N?-dihydroxyamidine diester (V) or 4-hydroxy-1,2,4-oxadiazoline (VI) of the formulae cited above, wherein R represents hydrogen, an alkyl and/or aryl radical, as a substitute for an amidine function of a medicament for improving the bioavailability of the medicament.
    Type: Application
    Filed: July 10, 2007
    Publication date: October 29, 2009
    Applicant: Drite Patentportfolio Beteilligungsgesellschaft mbH & Co. KG
    Inventors: Bernd Clement, Christiane Reeh